Capital Markets Laboratories

InVitae Corp (NYSE: NVTA) shares have had a somewhat volatile week of trading after short seller allegations against the company prompted a bullish analyst to defend InVitae’s model. What Happened On Oct. 11, a short seller article published on Seeking Alpha accused InVitae of being the...